Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts - ScienceDirect
British Journal of Haematology | Wiley Online Library
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
GitHub - denisagniel/longsurr: Functions to perform longitudinal surrogate marker analysis
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases - Incacare
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Surrogate markers for early and late stages of HIV disease progression | Download Table
Surrogate markers of infection: interrogation of the immune system | Biomarkers in Medicine
Surrogate Endpoints and Biomarkers | Basicmedical Key
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
Table I from Surrogate markers in HIV disease. | Semantic Scholar
Circulating miRNAs as a more appropriate Surrogate Marker for Ovarian Cancer | Cancer Community
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
Surrogate Endpoints | Evidera
Surrogate markers for GHB exposure in cell lines: 9783330038561: Medicine & Health Science Books @ Amazon.com
